Plant Expression Platforms May Be Better Option for Biopharma in the Global South

Mammalian cell-based biopharmaceutical manufacturing systems are complex, expensive, and, say the authors of a new study, not suited to producing medicines in resource-constrained environments. Plant-based protein expression platforms are a promising low-cost, more sustainable alternative. The post Plant Expression Platforms May Be Better Option for Biopharma in the Global South appeared first on GEN – Genetic Engineering and Biotechnology News.

Source: Genetic Engineering & Biotechnology News